MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,756,075 | +346.6% | 116,300 | 0.0% | 0.01% | +300.0% |
| Q3 2022 | $7,558,337 | -3.6% | 116,300 | +6.2% | 0.00% | 0.0% |
| Q2 2022 | $7,838,439 | -27.0% | 109,506 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,744,729 | +15.8% | 109,506 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,280,000 | +15.2% | 109,506 | +8.4% | 0.00% | 0.0% |
| Q3 2021 | $8,059,000 | +12.3% | 101,006 | +37.1% | 0.00% | 0.0% |
| Q2 2021 | $7,175,000 | -42.4% | 73,659 | -30.9% | 0.00% | -33.3% |
| Q1 2021 | $12,465,000 | -25.0% | 106,566 | -28.7% | 0.00% | -25.0% |
| Q4 2020 | $16,619,000 | -12.2% | 149,488 | -6.3% | 0.00% | -20.0% |
| Q3 2020 | $18,935,000 | +17.9% | 159,482 | +12.5% | 0.01% | 0.0% |
| Q2 2020 | $16,057,000 | +81.3% | 141,788 | +6.9% | 0.01% | +66.7% |
| Q1 2020 | $8,856,000 | -24.4% | 132,652 | +3.2% | 0.00% | 0.0% |
| Q4 2019 | $11,712,000 | +56.3% | 128,545 | +47.9% | 0.00% | +50.0% |
| Q3 2019 | $7,493,000 | -13.2% | 86,899 | +5.5% | 0.00% | -33.3% |
| Q2 2019 | $8,632,000 | -16.3% | 82,350 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,315,000 | +11.1% | 82,350 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $9,282,000 | -28.9% | 82,350 | +35.1% | 0.00% | -25.0% |
| Q3 2018 | $13,052,000 | – | 60,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |